EUDA Health shares surge 11.07% intraday after subsidiary signs convertible loan agreement with Shenzhen Innate Immune for cGMP facility upgrades and stem cell therapy innovation center in China.
ByAinvest
Tuesday, Jan 13, 2026 10:10 am ET1min read
EUDA--
EUDA Health surged 11.07% intraday, as its subsidiary signed a convertible loan agreement with Shenzhen Innute Immune on January 13, 2026, for a two-phase investment of up to 6 million RMB to upgrade cGMP facilities, establishing a stem cell therapy innovation center and expanding its Chinese regenerative medicine platform. The company, an Asian non-invasive healthcare provider operating in Singapore, Malaysia, and China, specializes in stem cell therapy, CRISPR gene editing treatments, and health supplements.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet